Apollon Wealth Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-26,439
| Closed | -$276K | – | 1161 |
|
|
2023
Q4 | $276K | Buy |
26,439
+60
| +0.2% | +$626 | 0.01% | 871 |
|
|
2023
Q3 | $269K | Sell |
26,379
-3,649
| -12% | -$37.2K | 0.01% | 737 |
|
|
2023
Q2 | $226K | Sell |
30,028
-285
| -0.9% | -$2.15K | 0.01% | 823 |
|
|
2023
Q1 | $268K | Buy |
30,313
+6,685
| +28% | +$59.2K | 0.02% | 712 |
|
|
2022
Q4 | $215K | Sell |
23,628
-235
| -1% | -$2.14K | 0.02% | 763 |
|
|
2022
Q3 | $193K | Sell |
23,863
-200
| -0.8% | -$1.62K | 0.02% | 726 |
|
|
2022
Q2 | $181K | Buy |
24,063
+4,125
| +21% | +$31K | 0.02% | 690 |
|
|
2022
Q1 | $187K | Sell |
19,938
-1,600
| -7% | -$15K | 0.01% | 701 |
|
|
2021
Q4 | $173K | Buy |
+21,538
| New | +$173K | 0.01% | 722 |
|